These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21725290)

  • 1. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
    Samplaski MK; Heston W; Elson P; Magi-Galluzzi C; Hansel DE
    Mod Pathol; 2011 Nov; 24(11):1521-9. PubMed ID: 21725290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
    Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
    Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
    Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
    Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH
    Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
    Davick JJ; Frierson HF; Smolkin M; Gru AA
    Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
    Haffner MC; Laimer J; Chaux A; Schäfer G; Obrist P; Brunner A; Kronberger IE; Laimer K; Gurel B; Koller JB; Seifarth C; Zelger B; Klocker H; Rasse M; Doppler W; Bander NH
    Mod Pathol; 2012 Aug; 25(8):1079-85. PubMed ID: 22460809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
    Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
    Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
    Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
    Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
    Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
    APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
    Minner S; Wittmer C; Graefen M; Salomon G; Steuber T; Haese A; Huland H; Bokemeyer C; Yekebas E; Dierlamm J; Balabanov S; Kilic E; Wilczak W; Simon R; Sauter G; Schlomm T
    Prostate; 2011 Feb; 71(3):281-8. PubMed ID: 20809553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.
    Zeng C; Ke ZF; Yang Z; Wang Z; Yang SC; Luo CQ; Wang LT
    Med Oncol; 2012 Sep; 29(3):2234-9. PubMed ID: 22009216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
    Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
    J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
    Baccala A; Sercia L; Li J; Heston W; Zhou M
    Urology; 2007 Aug; 70(2):385-90. PubMed ID: 17826525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
    Chen W; Lee Z; Awadallah A; Zhou L; Xin W
    Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.